Walnut protein source small molecule memory-enhancing peptides, walnut enzymatic hydrolysates, their preparation and application

Walnut protein hydrolysates were prepared by high hydrostatic pressure-assisted enzymatic hydrolysis and chemical synthesis, which solved the problem of low enzymatic hydrolysis efficiency caused by the dense structure of walnut protein. Small molecule memory-enhancing peptides EYWSPK and LAVKYQ were screened out, achieving efficient preparation and improved memory effects.

CN123106820APending Publication Date: 2026-11-17KUNMING UNIV OF SCI & TECH
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202610587535.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-04-29
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In existing technologies, walnut protein has a dense structure, and its enzyme cleavage sites are easily buried, resulting in low enzymatic hydrolysis efficiency and limited release of active peptides. Furthermore, effective in vivo verification of its memory-enhancing activity has not been conducted, making it difficult to efficiently prepare memory-enhancing peptides.

Method used

Walnut protein hydrolysate was prepared by a combination of high hydrostatic pressure-assisted enzymatic hydrolysis and chemical synthesis. High hydrostatic pressure pretreatment was used to disrupt the ordered structure of the protein and enhance its enzymatic hydrolysis properties. Small molecule memory-enhancing peptides EYWSPK and LAVKYQ were screened using computer-aided screening.

Benefits of technology

It significantly improves the enzymatic hydrolysis efficiency of walnut protein hydrolysate, enhances the release of small molecule peptides and improves memory activity, and has a good memory-improving function. It is suitable for preparing memory-improving drugs or health products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106820A_ABST
    Figure CN123106820A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of bioactive peptides, specifically relating to walnut protein-derived small-molecule memory-enhancing peptides, walnut enzymatic hydrolysates, their preparation, and applications. This invention provides two walnut protein-derived small-molecule memory-enhancing peptides, with amino acid sequences as shown in SEQ ID NO.1 and SEQ ID NO.2; these can be obtained through chemical synthesis using the amino acid sequences. This invention also provides a walnut protein enzymatic hydrolysate containing the two walnut protein-derived small-molecule memory-enhancing peptides, which can be prepared by a high hydrostatic pressure-assisted enzymatic hydrolysis method. This method effectively disrupts the ordered secondary structure of the protein, making the protein structure loose and increasing the contact sites between the enzyme and the protein, thereby significantly enhancing the enzymatic hydrolysis characteristics of walnut protein and increasing the release of small-molecule peptides. The walnut protein-derived small-molecule memory-enhancing peptides bind to the acetylcholinesterase (AChE) target protein, enabling both the walnut protein hydrolysate and the walnut protein-derived small-molecule memory-enhancing peptides to improve memory.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of bioactive peptides, specifically relating to walnut protein-derived small molecule memory-improving peptides, walnut enzymatic hydrolysates, their preparation and application. Background Technology

[0002] Memory decline and impairment has become a global public health problem, particularly prevalent among the elderly. Acetylcholinesterase (AChE) is a key hydrolytic enzyme in the cholinergic nervous system; overactivation leads to a decrease in the level of the neurotransmitter acetylcholine (ACh), resulting in memory and cognitive dysfunction. FDA-approved AChE inhibitors (donepezil, mannitol, rivastigmine) can alleviate memory impairment associated with ACh deficiency, but they are often accompanied by adverse reactions such as diarrhea, vomiting, headache, and muscle cramps. Therefore, there is an urgent need for food-derived AChE inhibitors that are naturally sourced, easily absorbed, and have no toxic side effects. Hydrolysates and small peptides derived from food proteins are considered to have great potential. Literature reports indicate that walnut protein is a good protein precursor for preparing peptides that improve memory.

[0003] Although reports have indicated that walnut protein peptides have memory-improving and enhancing effects, their preparation remains constrained by the structure of walnut protein. The dense molecular structure of walnut protein, with its highly ordered secondary and tertiary structures, easily obscures enzyme cleavage sites, leading to low release efficiency and limited enzymatic hydrolysis under conventional conditions, severely limiting its application. High hydrostatic pressure, as a non-thermal physical treatment technique, effectively breaks the compact conformation of natural proteins by compressing the internal cavities of protein molecules. This fully exposes enzyme cleavage sites that were originally buried within the molecule, thereby improving their accessibility and enhancing enzymatic hydrolysis characteristics and the release of bioactive peptides.

[0004] Chinese patent application number 202211422655.9, entitled "An Acetylcholinesterase Inhibitory Peptide from Walnut Meal and Its Preparation Method and Application", discloses a method for preparing acetylcholinesterase inhibitory peptides from walnut meal. The patent application proposes a method for preparing acetylcholinesterase inhibitory peptides from walnut meal using a restriction enzymatic hydrolysis combined with separation, purification and screening strategies.

[0005] Conventional enzymatic hydrolysis fails to consider the dense structure of walnut proteins and the burial of enzyme cleavage sites, resulting in low hydrolysis efficiency, limited release of active peptides, and a lack of effective in vivo validation of their memory-enhancing activity. Subsequent enrichment through separation and purification methods also struggle to fundamentally address the bottleneck of low release efficiency. Therefore, finding efficient ways to alter the structure of walnut proteins to enhance enzymatic hydrolysis efficiency and the release of small peptides, thereby improving the memory-enhancing effects of walnut peptides, is a current research focus. Summary of the Invention

[0006] This invention overcomes the shortcomings and deficiencies of the prior art, and its primary objective is to provide two small molecule memory-enhancing peptides derived from walnut protein.

[0007] Another objective of this invention is to provide a method for preparing the above-mentioned walnut protein-derived small molecule memory-enhancing peptide.

[0008] Another object of the present invention is to provide a walnut protein hydrolysate, comprising the above-mentioned walnut protein-derived small molecule memory-enhancing peptide.

[0009] Another object of the present invention is to provide a method for preparing the above-mentioned walnut protein hydrolysate.

[0010] Another object of the present invention is to provide the application of the above-mentioned walnut protein source small molecule memory-enhancing peptide or walnut protein hydrolysate.

[0011] To achieve the above objectives, the present invention adopts the following technical solution: This invention provides a small molecule memory-improving peptide derived from walnut protein, the amino acid sequence of which is shown in SEQ ID NO.1.

[0012] The present invention also provides a small molecule memory-improving peptide derived from walnut protein, the amino acid sequence of which is shown in SEQ ID NO.2.

[0013] This invention also provides a method for preparing the above-mentioned walnut protein source small molecule memory-enhancing peptide. The peptide is synthesized according to the amino acid sequence shown in SEQ ID NO.1 or SEQ ID NO.2 using a chemical synthesis method. The chemical synthesis method includes Fmoc solid-phase synthesis, which is performed using a solid-phase synthesizer. The Fmoc protecting group is removed by swelling and washing the dichlororesin, and then amino acids are added to carry out a condensation reaction. The process of removal-protection-condensation is repeated until all amino acids are linked.

[0014] The present invention also provides a walnut protein hydrolysate, which includes a walnut protein-derived small molecule memory-enhancing peptide with an amino acid sequence as shown in SEQ ID NO.1 or SEQ ID NO.2. The walnut protein-derived small molecule memory-enhancing peptide has memory-enhancing activity, which is manifested by the binding of the walnut protein-derived small molecule memory-enhancing peptide to the AChE target protein and its AChE inhibitory activity.

[0015] This invention also provides a method for preparing the above-mentioned walnut protein hydrolysate, which employs a high hydrostatic pressure-assisted enzymatic hydrolysis method, specifically including the following steps: (1) High hydrostatic pressure pretreatment of walnut meal protein: Walnut meal protein powder was mixed with deionized water, pH was adjusted, and the mixture was placed in a batch ultra-high pressure equipment for treatment. The treated sample was dried and stored to obtain pretreated walnut meal protein. (2) Alkali dissolution and acid precipitation extraction of walnut protein isolate: pretreated walnut meal protein is mixed with deionized water, pH is adjusted for alkali extraction, the supernatant is centrifuged to obtain alkali extract, the alkali extract is stirred and pH is adjusted for acid precipitation, then the precipitated protein is collected by centrifugation and dried to obtain walnut protein isolate. (3) Preparation of walnut protein hydrolysate: walnut protein isolate is dispersed in water, trypsin and plant hydrolase are added for enzymatic hydrolysis and enzyme inactivation; finally, the mixture is centrifuged, the supernatant is collected and dried to obtain walnut protein hydrolysate.

[0016] Furthermore, the peptide sequences in the above-mentioned walnut protein hydrolysates were identified by LC-MS / MS liquid chromatography-mass spectrometry, and a peptide database of walnut protein hydrolysates was constructed. In addition, computer screening was used to obtain the above-mentioned walnut protein source small molecule memory-enhancing peptides EYWSPK and LAVKYQ.

[0017] Furthermore, in steps (1), (2) and (3), drying involves drying the protein solution to a moisture content of less than 6.5%, using one of the following methods: freeze drying, vacuum drying, or spray drying.

[0018] Furthermore, in step (1), the ratio of walnut meal protein powder to deionized water is 1:8-1:10 (w / v, g / mL), and the pH is adjusted to 6.5-7.5; the batch ultra-high pressure equipment is placed under the condition of 350-400MPa for 2-4 hours.

[0019] Furthermore, in step (2), the mass-to-volume ratio of pretreated walnut meal protein to deionized water is 1:15 in g / mL; during alkali extraction, 5-7 mol / L sodium hydroxide solution is used to adjust the pH to 8.0-9.0, and the alkali extract is stirred at room temperature for 1-2 hours. During acid precipitation, the pH is adjusted to 4.0-5.0.

[0020] Furthermore, in step (3), the ratio of walnut protein isolate to deionized water is 1:8-1:10 (w / v, g / mL); the enzyme activity of trypsin and compound plant hydrolase is 8000-10000 U / g, and the amount added is 0.5%-1.0% of the walnut protein isolate protein content; the enzymatic hydrolysis pH is 6.5-7.5, the temperature is 50-55℃, and the time is 2-4h.

[0021] The present invention also provides the application of the above two walnut protein source small molecule memory-improving peptides or walnut protein hydrolysates in the preparation of memory-improving drugs or health products that help improve memory.

[0022] The present invention has the following advantages and effects compared with the prior art: (1) The walnut protein-derived small molecule memory-improving peptide provided by the present invention has a clear and distinct structure and can be obtained by chemical synthesis. The walnut protein hydrolysate containing the walnut protein-derived small molecule memory-improving peptide provided by the present invention can be prepared by high hydrostatic pressure-assisted walnut protein hydrolysis technology.

[0023] (2) The present invention uses high hydrostatic pressure to pretreat walnut protein and then enzymatically hydrolyzes it, which can effectively destroy the ordered secondary structure of the protein, make the protein structure loose, increase the contact sites between the enzyme and the protein, thereby significantly enhancing the enzymatic hydrolysis characteristics of walnut protein and enhancing the release of small molecule peptides.

[0024] (3) The present invention uses computer-assisted bioinformatics screening to screen potential small molecule memory-improving peptides from a massive walnut protein peptide library, which greatly narrows the scope of experimental verification and saves time and experimental costs.

[0025] (4) The walnut protein hydrolysate prepared by high hydrostatic pressure of the present invention has a good effect on improving the memory impairment induced by scopolamine in C57BL / 6N mice, which is reflected by the binding of walnut protein-derived small molecule memory-improving peptides to acetylcholinesterase AChE target protein; the walnut protein hydrolysate and walnut protein-derived small molecule memory-improving peptides provided by the present invention have the effect of alleviating cognitive and memory impairment, and can be used to prepare memory-improving drugs or memory-improving health products, and can also be used in combination with other health products or food additives. Attached Figure Description

[0026] Figure 1 This is a diagram showing the proportion of secondary structures of walnut protein prepared in Examples 1, 6, 7 and Comparative Examples 1-4.

[0027] Figure 2 This is a graph showing the molecular weight distribution of walnut protein hydrolysates prepared in Examples 1, 6, 7 and Comparative Examples 1-4.

[0028] Figure 3 The graph shows the molecular docking results of the small molecule memory-improving peptides from walnut protein source screened in Example 5 and the walnut peptides screened in Comparative Example 5 with AChE enzyme. Detailed Implementation

[0029] The present invention will be further described in detail below with reference to specific embodiments, but the implementation of the present invention is not limited to the scope shown in the embodiments. These embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, after reading the contents of this invention, those skilled in the art can make various modifications to the present invention, and these equivalent changes also fall within the scope defined by the appended claims.

[0030] Example 1 A method for preparing walnut protein hydrolysate Walnut meal protein powder was mixed with deionized water at a ratio of 1:10 (w / v, g / mL), the pH was adjusted to 7.0, and the mixture was placed in a batch ultra-high pressure equipment and treated at 400 MPa for 4 hours. After treatment, the sample was dried and stored at 4℃ to obtain pretreated walnut meal protein. Pretreated walnut meal protein was added to deionized water at a ratio of 1g:15mL and subjected to alkaline extraction with 6mol / L sodium hydroxide solution. The pH was adjusted to 9.0 during alkaline extraction. The supernatant was collected by centrifugation to obtain the alkaline extract. The alkaline extract was stirred at room temperature for 2 hours and the pH was adjusted to 4.0 for acid precipitation. The precipitated protein was then collected by centrifugation and dried to obtain walnut protein isolate WP400. The protein was then dispersed in deionized water at a ratio of 1:8 (w / v, g / mL), and trypsin and a compound plant hydrolase (both with an enzyme activity of 10000 U / g) were added (each accounting for 1% of the protein weight separated from walnut protein). Hydrolysis was carried out at pH 7.0 and 55℃ for 4 hours, followed by inactivation at 95℃ for 20 minutes. Finally, the mixture was centrifuged at 8000 rpm and 4℃ for 10 minutes, and the supernatant was collected and dried to obtain walnut protein hydrolysate WPH400.

[0031] Example 2 Methods for determining the secondary structure and surface hydrophobicity of walnut protein This embodiment, based on Example 1, uses WP400 samples for FITR determination. The determination method is as follows: the protein sample is mixed with dried KBr, pressed into a thin film, and then analyzed by Fourier transform infrared spectroscopy. The range is 400~4000 cm⁻¹. -1 The spectrum was recorded within a certain range, and multiple scans were performed to characterize the protein's secondary structure.

[0032] This example, based on Example 1, uses WP400 samples to determine surface hydrophobicity. A 0.01 mol / L phosphate-buffered saline (PBS, pH 7.0) solution was prepared. Samples were diluted in PBS to concentrations of 0.05, 0.10, 0.20, 0.30, and 0.40 mg / mL, then centrifuged at 10,000 × g for 10 min, and the supernatant was collected. For measurement, 2.0 mL of each supernatant was mixed with 40 µL of 8.0 mmol / L ANS (8-amino-1-naphthalenesulfonic acid), vortexed, and allowed to equilibrate for 10 min. Fluorescence intensity (excitation wavelength 390 nm; emission wavelength 470 nm; slit width 5 nm) was recorded on an F-4500 fluorescence spectrophotometer. H0 was calculated as the slope of a linear regression of fluorescence intensity with protein concentration.

[0033] Example 3 Methods for determining the degree of hydrolysis and molecular weight distribution of walnut protein hydrolysates This embodiment, based on Example 1, determines the degree of hydrolysis and molecular weight distribution of the WPH400 sample. The degree of hydrolysis is defined as the ratio of amino nitrogen (-NH2) to total nitrogen in the hydrolysis products. The content of -NH2 and total nitrogen in the WPH400 supernatant was determined by ninhydrin colorimetry and Kjeldahl nitrogen determination, respectively. Molecular weight determination of WPH400: The molecular weight distribution of walnut protein hydrolysates was determined by liquid chromatography. Specific conditions were as follows: Column: TSKgel G2000 SWXL column (7.8 mm × 300.0 mm, Tosoh Bioscience, Honshu, Japan); Sample concentration: 2.0 mg / mL; Injection volume: 10 µL; Mobile phase: 20% (v / v) acetonitrile (0.1% (v / v) trifluoroacetic acid); Flow rate: 0.5 mL / min; Column temperature: room temperature; UV detection wavelength: 220 nm. The molecular weight distribution was determined using calibration curves constructed using standards cytochrome c, Gly-Gly-Tyr-Arg, Gly-Gly-Gly, bacitracin, and aprotinin.

[0034] Example 4 Methods for evaluating the in vitro and in vivo memory-improving activity of walnut protein hydrolysis This embodiment, based on Example 1, uses WPH400 samples to determine in vitro AChE inhibitory activity and in vivo Morris water maze behavior.

[0035] Method for determining the in vitro AChE inhibition rate: 125 μL DTNB (3 mM), 30 μL ATCI (7.5 mM), 50 μL PBS (5 mM, pH 8.0), and 50 μL sample (30 mg / mL, based on protein concentration) were added to 96-well plates, mixed, and incubated at 37°C for 15 min. After incubation, 30 μL of acetylcholinesterase (AChE) (0.22 U / mL) was added to begin the assay. The assay was performed using a microplate reader. The measurement wavelength was 412 nm, and the measurement time was 15 min. The formula for calculating the inhibitory activity of the sample against acetylcholinesterase AChE is as follows:

[0036] Among them, A 样品 A represents the absorbance of the sample group. 样品空白 For the sample group without enzymes, A 对照 For the enzyme-added but sample-free group, A 对照空白 This is the sample group without enzymes or samples.

[0037] Methods for measuring in vivo Morris water maze behavior: Animal experiments: Eight-week-old male C57BL / 6N mice (weighing 20-22g, purchased from Beijing Vital River Biotechnology Co., Ltd.) were used in the experiment and housed at the Animal Experiment Center of Kunming University of Science and Technology. After one week of acclimatization, they were maintained at a temperature of 22±1°C and a 12h / 12h light cycle. The mice were randomly divided into 5 groups (n=12 per group). The walnut peptide group was administered 0.2mL of WPH400 solution (400mg / kg bw) prepared with physiological saline by gavage daily for 4 weeks, while the control and model groups were administered the same volume of physiological saline by gavage daily. Starting from the fourth week, the model group and the walnut peptide group were injected intraperitoneally with 0.2mL of scopolamine (3mg / kg bw) daily for 7 days to induce memory and cognitive impairment, while the control group was injected intraperitoneally with the same volume of physiological saline daily.

[0038] Starting from the fourth week, water maze behavioral tests were conducted concurrently. The first five days were the training period, and the sixth day was the formal testing period. Mice in the walnut peptide group were administered WPH400 via gavage for 30 minutes, followed by an intraperitoneal injection of scopolamine. The Morris water maze test was then performed 30 minutes after the scopolamine injection. The mice were euthanized after the final behavioral test.

[0039] Morris water maze test: The water maze was a circular pool divided into four zones, with an invisible escape platform located 1.5 cm below the surface. A localization and navigation experiment was then conducted, recording the mice's swimming routes (total swimming distance) and the time they took to find the platform (escape latency). Next, a spatial exploration experiment was performed, in which the platform was removed, recording the number of times the mice crossed the platform, the time spent in the target platform area (time spent in the target quadrant), and the swimming distance (distance spent in the target quadrant).

[0040] Example 5 A method for screening AChE inhibitory peptides, the specific steps of which are as follows: The peptide sequences of the walnut protein hydrolysate obtained in Example 1 were identified using UPLC-Q-Orbitrap-MS / MS (mass spectrometry resolution conditions were: precursor mass tolerance 20-30 ppm, fragment mass tolerance 0.02-0.06 Da, peptide length 2-30 amino acid residues, and minimum identification score 36). After processing the raw data with ProteoWizard 3.0, the data was imported into the PepOS 3.2 proteomics platform (http: / / www.peposx.com) for comparison and analysis, thus achieving peptide sequence identification. 2000 peptide sequences were identified from WPH400. Based on the structural characteristics of the AChE enzyme active site and substrate competition mechanism, peptides containing basic amino acids were selected for screening. To increase the probability of obtaining bioactive peptides, peptides with a PeptideRanker score > 0.5 were selected. Subsequently, to ensure the peptides are fully absorbed by the human body, peptides with BBB and HIA scores greater than 0.5 were screened. Finally, molecular docking was performed, selecting peptides with a CDOCKER ENERGY score <-95 kcal / mol. For peptides with lower scores, the key amino acids and interactions were analyzed. In this embodiment, the walnut protein-derived small-molecule memory-enhancing peptides EYWSPK and LAVKYQ of this invention were obtained under these standards, and their AChE inhibitory activity at 1 mg / mL was tested.

[0041] Example 6 A method for preparing walnut protein hydrolysate Walnut meal protein powder was mixed with deionized water at a ratio of 1:8 (w / v, g / mL), the pH was adjusted to 6.5, and the mixture was placed in a batch ultra-high pressure equipment and treated at 350 MPa for 2 hours. After treatment, the sample was dried and stored at 4℃ to obtain pretreated walnut meal protein. Pretreated walnut meal protein was added to deionized water at a ratio of 1g:15mL and subjected to alkaline extraction with 5mol / L sodium hydroxide solution. The pH was adjusted to 8.0 during alkaline extraction. The supernatant was collected by centrifugation to obtain the alkaline extract. The alkaline extract was stirred at room temperature for 1 hour and the pH was adjusted to 4.5 for acid precipitation. The precipitated protein was then collected by centrifugation and dried to obtain walnut protein isolate WP350. The protein was then dispersed in deionized water at a ratio of 1:9 (w / v, g / mL), and trypsin and a compound plant hydrolase (both with an enzyme activity of 8000 U / g) were added (each adding 0.5% of the walnut protein isolate). Hydrolysis was carried out at pH 6.5 and 50℃ for 2 hours, followed by inactivation at 95℃ for 20 minutes. Finally, the mixture was centrifuged at 8000 rpm and 4℃ for 10 minutes, and the supernatant was collected and dried to obtain walnut protein hydrolysate WPH350.

[0042] The protein secondary structure content and surface hydrophobicity of WP350 were determined using the method described in Example 2. Simultaneously, the degree of hydrolysis and molecular weight distribution of WPH350 were analyzed using the method described in Example 3. Furthermore, its AChE inhibitory activity was determined using the method described in Example 4, and the in vivo improvement effect of WPH350 on memory function was evaluated through animal behavioral experiments.

[0043] Example 7 A method for preparing walnut protein hydrolysate Walnut meal protein powder was mixed with deionized water at a ratio of 1:9 (w / v, g / mL), the pH was adjusted to 7.5, and the mixture was placed in a batch ultra-high pressure equipment and treated at 400 MPa for 3 hours. After treatment, the sample was dried and stored at 4℃ to obtain pretreated walnut meal protein. Pretreated walnut meal protein was added to deionized water at a ratio of 1g:15mL and subjected to alkaline extraction with 7mol / L sodium hydroxide solution. The pH was adjusted to 8.5 during alkaline extraction. The supernatant was collected by centrifugation to obtain the alkaline extract. The alkaline extract was stirred at room temperature for 1.5h and the pH was adjusted to 5.0 for acid precipitation. The precipitated protein was then collected by centrifugation and dried to obtain walnut protein isolate WP400-2. The protein was then dispersed in deionized water at a ratio of 1:10 (w / v, g / mL), and trypsin and a compound plant hydrolase (both with an enzyme activity of 9000 U / g) were added (each adding 0.75% of the walnut protein isolate). Hydrolysis was carried out at pH 7.5 and 55℃ for 3 hours, followed by inactivation at 95℃ for 20 minutes. Finally, the mixture was centrifuged at 8000 rpm and 4℃ for 10 minutes, and the supernatant was collected and dried to obtain walnut protein hydrolysate WPH400-2.

[0044] The protein secondary structure content and surface hydrophobicity of WP400-2 were determined using the method described in Example 2. Simultaneously, the degree of hydrolysis and molecular weight distribution of WPH400-2 were analyzed using the method described in Example 3. Furthermore, its AChE inhibitory activity was determined using the method described in Example 4, and the in vivo improvement effect of WPH400-2 on memory function was evaluated through animal behavioral experiments.

[0045] Comparative Example 1 Walnut meal protein was mixed with deionized water at a ratio of 1:10 (w / v, g / mL), the pH was adjusted to 7.0, and the treated sample was freeze-dried and stored at 4℃. The pretreated protein was added to deionized water at a ratio of 1g:15mL. The pH was adjusted to 9.0 with 6mol / L sodium hydroxide solution. The supernatant was collected by centrifugation to obtain an alkaline extract. The alkaline extract was stirred at room temperature for 2 hours and the pH was adjusted to 4.0 for acid precipitation. The precipitated protein was then collected by centrifugation to obtain walnut protein isolate WP, which is the pretreated walnut meal protein. The pretreated walnut meal protein was then dispersed in deionized water at a ratio of 1:8 (w / v, g / mL), and trypsin and plant hydrolase (each added at 1% of the walnut protein's protein content) were added. Hydrolysis was carried out at pH 7.0 and 55℃ for 4 hours, followed by inactivation at 95℃ for 20 minutes. Finally, the mixture was centrifuged at 8000 rpm and 4℃ for 10 minutes, and the supernatant was collected and dried to obtain the walnut protein hydrolysate WPH.

[0046] The protein secondary structure content and surface hydrophobicity of WP were determined using the method described in Example 2. Simultaneously, the degree of hydrolysis and molecular weight distribution of WPH were analyzed using the method described in Example 3. Furthermore, its AChE inhibitory activity was determined using the method described in Example 4, and the in vivo improvement effect of WPH on memory function was evaluated through animal behavioral experiments.

[0047] Comparative Example 2 Walnut meal protein powder was mixed with deionized water at a ratio of 1:10 (w / v, g / mL), the pH was adjusted to 7.0, and the mixture was placed in a batch ultra-high pressure equipment and treated at a low pressure of 100 MPa for 4 hours. After treatment, the sample was freeze-dried and stored at 4℃ to obtain pretreated walnut meal protein. Pretreated walnut meal protein was added to deionized water at a ratio of 1g:15mL. The pH was adjusted to 9.0 with 6mol / L sodium hydroxide solution. The supernatant was collected by centrifugation to obtain an alkaline extract. The alkaline extract was stirred at room temperature for 2 hours and the pH was adjusted to 4.0 for acid precipitation. The precipitated protein was then collected by centrifugation and dried to obtain walnut protein isolate WP100. The protein was then dispersed in deionized water at a ratio of 1:8 (w / v), and trypsin and plant hydrolase (each added at 1.0% of the weight of the isolated walnut protein) were added. Hydrolysis was carried out at pH 7.0 and 55°C for 4 hours, followed by inactivation at 95°C for 20 minutes. Finally, the mixture was centrifuged at 8000 rpm and 4°C for 10 minutes, and the supernatant was collected and freeze-dried to obtain walnut protein hydrolysate WPH100.

[0048] The protein secondary structure content and surface hydrophobicity of WP100 were determined using the method described in Example 2. Simultaneously, the degree of hydrolysis and molecular weight distribution of WPH100 ​​were analyzed using the method described in Example 3. Furthermore, its AChE inhibitory activity was determined using the method described in Example 4, and the in vivo improvement effect of WPH100 ​​on memory function was evaluated through animal behavioral experiments.

[0049] Comparative Example 3 Walnut meal protein powder was mixed with deionized water at a ratio of 1:10 (w / v, g / mL), the pH was adjusted to 7.0, and the mixture was placed in a batch ultra-high pressure equipment and treated at 200 MPa for 4 hours. After treatment, the sample was freeze-dried and stored at 4℃ to obtain pretreated walnut meal protein. Pretreated walnut meal protein was added to deionized water at a ratio of 1g:15mL. The pH was adjusted to 9.0 with 6mol / L sodium hydroxide solution. The supernatant was collected by centrifugation to obtain an alkaline extract. The alkaline extract was stirred at room temperature for 2 hours and the pH was adjusted to 4.0 for acid precipitation. The precipitated protein was then collected by centrifugation and dried to obtain walnut protein isolate WP200. The protein was then dispersed in deionized water at a ratio of 1:8 (w / v, g / mL), and trypsin and plant hydrolase (each added at 1.0% of the weight of the isolated walnut protein) were added. Hydrolysis was carried out at pH 7.0 and 55℃ for 4 hours, followed by inactivation at 95℃ for 20 minutes. Finally, the mixture was centrifuged at 8000 rpm and 4℃ for 10 minutes, and the supernatant was collected and freeze-dried to obtain walnut protein hydrolysate WPH200.

[0050] The protein secondary structure content and surface hydrophobicity of WP200 were determined using the method described in Example 2. Simultaneously, the degree of hydrolysis and molecular weight distribution of WPH200 were analyzed using the method described in Example 3. Furthermore, its AChE inhibitory activity was determined using the method described in Example 4, and the in vivo improvement effect of WPH200 on memory function was evaluated through animal behavioral experiments.

[0051] Comparative Example 4 Walnut meal protein powder was mixed with deionized water at a ratio of 1:10 (w / v, g / mL), the pH was adjusted to 7.0, and the mixture was placed in a batch ultra-high pressure equipment and treated at 300 MPa for 4 hours. After treatment, the sample was freeze-dried and stored at 4℃ to obtain pretreated walnut meal protein. Pretreated walnut meal protein was added to deionized water at a ratio of 1g:15mL. The pH was adjusted to 9.0 with 6mol / L sodium hydroxide solution. The supernatant was collected by centrifugation to obtain an alkaline extract. The alkaline extract was stirred at room temperature for 2 hours and the pH was adjusted to 4.0 for acid precipitation. The precipitated protein was then collected by centrifugation and dried to obtain walnut protein isolate WP300. The protein was then dispersed in deionized water at a ratio of 1:8 (w / v, g / mL), and trypsin and plant hydrolase (each added at 1.0% of the weight of the isolated walnut protein) were added. Hydrolysis was carried out at pH 7.0 and 55°C for 4 hours, followed by inactivation at 95°C for 20 minutes. Finally, the mixture was centrifuged at 8000 rpm and 4°C for 10 minutes, and the supernatant was collected and freeze-dried to obtain walnut protein hydrolysate WPH300.

[0052] The protein secondary structure content and surface hydrophobicity of WP300 were determined using the method described in Example 2. Simultaneously, the degree of hydrolysis and molecular weight distribution of WPH300 were analyzed using the method described in Example 3. Furthermore, its AChE inhibitory activity was determined using the method described in Example 4, and the in vivo improvement effect of WPH300 on memory function was evaluated through animal behavioral experiments.

[0053] Comparative Example 5 The polypeptide sequences of the walnut protein hydrolysate obtained in Example 1 were identified using UPLC-Q-Orbitrap-MS / MS. After processing the raw data with ProteoWizard 3.0, the data was imported into the PepOS 3.2 proteomics platform (http: / / www.peposx.com) for alignment analysis, thereby identifying the peptide sequences. 2000 polypeptide sequences were identified from WPH400. The precursor peptides EYWS ​​and LAVK of the walnut protein source small molecule memory-enhancing peptides EYWSPK and LAVKYQ of this invention were selected as control peptides. They were analyzed using the same screening and evaluation methods as in Example 5, and their AChE inhibitory activity was measured. Based on the AChE active site structure and substrate competition mechanism, PeptideRanker, BBB, and HIA predictions were performed on EYWS ​​and LAVK, and further molecular docking analysis was conducted to analyze their docking stability values ​​(CDOCKER ENERGY).

[0054] The specific results of the analysis are as follows: Table 1. Surface hydrophobicity of walnut proteins obtained in Examples 1, 6, and 7, and Comparative Examples 1-4

[0055] Table 2. Degree of hydrolysis and AChE inhibition rate of walnut protein hydrolysates obtained in Examples 1, 6, and 7, and Comparative Examples 1-4.

[0056] Table 3. Effects of Examples 1, 6, and 7, and Comparative Examples 1-4 on behavioral indicators in the mouse water maze.

[0057] Note: # Compared with the model group,p <0.05, ## compared with the control group p <0.01; Compared with the model group, p <0.05, Compared with the model group, p <0.01; Compared with the model group, p <0.001.

[0058] Table 4. Identification and activity prediction of walnut AChE inhibitory peptide sequences.

[0059] From Table 1, which shows the surface hydrophobicity of walnut protein, the WP400 prepared in Example 1, compared to the walnut protein in Comparative Example 1 that was not treated with high hydrostatic pressure (427.5 µmol / g), achieved a maximum surface hydrophobicity value of 1020.37 µmol / g, which is very close to the results of Examples 6 (997.69 µmol / g) and 7 (1014.25 µmol / g). The results indicate that the 400 MPa treatment in Example 1 maximized the expansion of walnut protein molecules.

[0060] Figure 1 The diagrams showing the proportions of secondary structures of walnut protein prepared in Examples 1, 6, 7 and Comparative Examples 1-4 also verify this result. The total proportions of α-helices and β-sheets in Examples 1, 6, 7 and Comparative Example 4 are significantly smaller than those in Comparative Examples 1-3. The results indicate that high hydrostatic pressure treatment can make the structure of walnut protein more loose, and the effect is significant when the treatment conditions are above 300 MPa.

[0061] As shown in Table 2, the walnut protein hydrolysate WPH400 prepared using the method in Example 1 exhibited significantly better degree of hydrolysis and AChE inhibition rate than Comparative Examples 1-4. Similarly, the walnut protein hydrolysates prepared in Examples 6 and 7 also showed significantly better degree of hydrolysis and AChE inhibition rate than Comparative Examples 1-4. Specifically, the degree of hydrolysis of walnut protein hydrolysate WPH400 prepared in Example 1 reached 23.10%, the degree of hydrolysis of walnut protein hydrolysate prepared in Example 6 reached 22.57%, and the degree of hydrolysis of walnut protein hydrolysate prepared in Example 7 reached 23.33%. This indicates that treatment at 350-400 MPa resulted in a looser walnut protein structure and more complete enzymatic hydrolysis, which facilitates the release of more peptides with AChE inhibitory activity.

[0062] Figure 2 The molecular weight distribution of walnut protein hydrolysates prepared in Examples 1, 6, 7, and Comparative Examples 1-4 is shown in the diagram. Figure 2It can be seen that the walnut protein hydrolysates obtained in Examples 1, 6, and 7 have smaller molecular weights and more concentrated distributions. In the walnut protein hydrolysate obtained in Example 1, the proportion of components with molecular weights less than 1000 Da reaches more than 86.89%, while the proportion of macromolecular components is relatively low. In the walnut protein hydrolysate obtained in Example 6, the proportion of components with molecular weights less than 1000 Da reaches more than 86.40%, and in the walnut protein hydrolysate obtained in Example 7, the proportion of components with molecular weights less than 1000 Da reaches more than 84.50%. In contrast, the products obtained in Comparative Examples 1-4 have larger molecular weights and wider distributions, indicating that their enzymatic hydrolysis is insufficient. The above results show that the method described in this invention can significantly enhance the enzymatic hydrolysis characteristics of walnut protein and is beneficial for obtaining small molecule peptides with high AChE inhibitory activity.

[0063] Table 3 shows that scopolamine treatment increased the escape latency and total distance to the target area in the Morris water maze behavioral test for C57BL / 6N mice (i.e., the model group) compared to the control group. Similarly, scopolamine treatment reduced the number of times C57BL / 6N mice entered the target area. This indicates that the C57BL / 6N mice in the model group could not accurately remember and locate the target area. However, treatment with the walnut protein hydrolysate WPH400 prepared at 400 MPa in Example 1 (the treatment group) significantly increased the localization of the target area by C57BL / 6N mice, and its activity was significantly higher than that of the walnut protein hydrolysates prepared at 0-300 MPa (Comparative Examples 1-4). The walnut protein hydrolysates prepared in Examples 6 and 7 also showed better effects than those in Comparative Examples 1-4. As expected, Examples 1, 6, and 7 showed stronger memory-improving effects compared to Comparative Examples 1-4. This is consistent with the significant increase in AChE inhibition rate observed in the in vitro AChE inhibition rate assay of the embodiments of the present invention.

[0064] Table 4 shows that the binding energies of the AChE inhibitory peptides LAVKYQ and EYWSPK screened from WPH400 to AChE are -125.629 and -127.804 kcal / mol, respectively, indicating their ability to bind to AChE. Furthermore, their high BBB and HIA prediction values ​​suggest good absorption potential. In contrast, the CDOCKER ENERGY of the walnut peptides EYWS ​​and LAVK screened in Comparative Example 5 to AChE are -87.2328 and -83.412 kcal / mol, respectively, indicating weaker binding ability and lower bioactivity scores and absorption prediction values. The AChE inhibitory activities of 1 mg / mL EYWSPK and LAVKYQ are 31.82% and 26.23%, respectively, while the inhibitory activities of EYWS ​​and LAVK are 20.98% and 23.09%, respectively.

[0065] Figure 3The diagram shows the molecular docking results of the walnut protein-derived small molecule memory-improving peptides screened in Example 5 and Comparative Example 5 with AChE enzyme. Figure 3 Molecular docking results showed that both could embed themselves into the AChE active pocket and bind to key amino acid residues through hydrogen bonds and hydrophobic interactions, thereby inhibiting AChE activity.

[0066] The above results indicate that LAVKYQ and EYWSPK have good AChE inhibition potential and can be used as active ingredients to improve memory and cognitive function.

[0067] In summary, the high hydrostatic pressure pretreatment at 350-400 MPa of this invention can efficiently destroy the ordered structure of walnut protein, making the protein structure loose and increasing the contact sites between enzymes and walnut protein, thereby significantly enhancing the enzymatic hydrolysis characteristics of walnut protein and making it more conducive to the release of small molecule memory peptides.

[0068] The above embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above embodiments. Any changes, modifications, substitutions, combinations, or simplifications made without departing from the spirit and principle of the present invention shall be considered equivalent substitutions and shall be included within the protection scope of the present invention.

Claims

1. A small molecule memory-enhancing peptide derived from walnut protein, characterized in that, The amino acid sequence is shown in SEQ ID NO.

1.

2. A small molecule memory-enhancing peptide derived from walnut protein, characterized in that, The amino acid sequence is shown in SEQ ID NO.

2.

3. The method for preparing the walnut protein-derived small molecule memory-enhancing peptide according to claim 1 or 2, characterized in that, The amino acid sequence according to claim 1 or 2 is synthesized by a chemical synthesis method, which includes the Fmoc solid-phase synthesis method. The Fmoc solid-phase synthesis method is performed using a solid-phase synthesizer. The dichlororesin is swollen and washed, and after removing the Fmoc protecting group, amino acids are added to carry out a condensation reaction. The process of removal-protection-condensation is repeated until all amino acids are linked.

4. A walnut protein hydrolysate, characterized in that, The walnut protein hydrolysate includes the walnut protein-derived small molecule memory-enhancing peptide as described in claim 1 or 2.

5. The method for preparing the walnut protein hydrolysate according to claim 4, characterized in that, The high hydrostatic pressure-assisted enzymatic hydrolysis method includes the following steps: (1) High hydrostatic pressure pretreatment of walnut meal protein: Walnut meal protein powder was mixed with deionized water, pH was adjusted, and the mixture was placed in a batch ultra-high pressure equipment for treatment. The treated sample was dried and stored to obtain pretreated walnut meal protein. (2) Alkali dissolution and acid precipitation extraction of walnut protein isolate: pretreated walnut meal protein is mixed with deionized water, pH is adjusted for alkali extraction, the supernatant is centrifuged to obtain alkali extract, the alkali extract is stirred and pH is adjusted for acid precipitation, then the precipitated protein is collected by centrifugation and dried to obtain walnut protein isolate. (3) Preparation of walnut protein hydrolysate: walnut protein isolate is dispersed in water, trypsin and plant hydrolase are added for enzymatic hydrolysis and enzyme inactivation; finally, the mixture is centrifuged, the supernatant is collected and dried to obtain walnut protein hydrolysate.

6. The preparation method according to claim 5, characterized in that, In steps (1), (2) and (3), the drying process involves drying the protein solution to a moisture content of less than 6.5%, using one of the following methods: freeze drying, vacuum drying, or spray drying.

7. The preparation method according to claim 5, characterized in that, In step (1), the ratio of walnut meal protein powder to deionized water is 1:8-1:10 in g / mL, and the pH is adjusted to 6.5-7.5; the batch ultra-high pressure equipment is used for processing at 350-400MPa for 2-4 hours.

8. The preparation method according to claim 5, characterized in that, In step (2), the mass-to-volume ratio of the pretreated walnut meal protein to deionized water is 1:15 (g / mL); during the alkali extraction, 5-7 mol / L sodium hydroxide solution is used to adjust the pH to 8.0-9.0, and the alkali extract is stirred at room temperature for 1-2 hours. During acid precipitation, the pH is adjusted to 4.0-5.

0.

9. The preparation method according to claim 5, characterized in that, In step (3), the ratio of walnut protein isolate to water is 1:8-1:10 (g / mL); the enzyme activity of trypsin and compound plant hydrolase is 8000-10000 U / g, and the amount added is 0.5%-1.0% of the walnut protein isolate; the enzymatic hydrolysis pH is 6.5-7.5, the temperature is 50-55℃, and the time is 2-4h.

10. The use of the walnut protein-derived small molecule memory-enhancing peptide of claim 1 or 2, or the walnut protein hydrolysate of claim 4, in the preparation of memory-enhancing drugs or health products that assist in improving memory.

Citation Information

Patent Citations

  • Walnut acetylcholinesterase inhibitory peptide and its application

    CN115677826B